Loss of Zap-70 and low molecular weight phosphotyrosine phosphatase occurs after therapy in a patient with B-chronic lymphocytic leukemia

Leukemia. 2005 Aug;19(8):1503-5. doi: 10.1038/sj.leu.2403793.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents / adverse effects*
  • Female
  • Humans
  • Isoenzymes / deficiency
  • Leukemia, Lymphocytic, Chronic, B-Cell / drug therapy
  • Leukemia, Lymphocytic, Chronic, B-Cell / enzymology*
  • Middle Aged
  • Protein Tyrosine Phosphatases / deficiency*
  • Protein-Tyrosine Kinases / deficiency*
  • Proto-Oncogene Proteins / deficiency
  • Steroids / adverse effects
  • Steroids / therapeutic use
  • ZAP-70 Protein-Tyrosine Kinase

Substances

  • Antineoplastic Agents
  • Isoenzymes
  • Proto-Oncogene Proteins
  • Steroids
  • Protein-Tyrosine Kinases
  • ZAP-70 Protein-Tyrosine Kinase
  • ZAP70 protein, human
  • ACP1 protein, human
  • Protein Tyrosine Phosphatases